More notably, preclinical studies have shown that the Pluronic‐modified leptin nanomedicine (Lep(ss)‐P85) can bypass the BBB to increase the accumulation of the delivered drug in the brain by 60%, thereby offering a new treatment option for leptin‐resistant obesity.[173] Additionally, Wan et al. The gene discussed is LEP; the disease is obesity disorder.